GLP-1 therapies influence pathways tied to addiction and reward, according to the Endocrine Society A randomized clinical trial published in JAMA Psychiatry found semaglutide reduced alcohol cravings and consumption Users commonly report: Reduced desire to drink Feeling full faster when drinking Less reward from alcohol The data: early, but directionally consistent While long-term industry sales data is still developing, the early signals from clinical studies, observational research, and population polling all point in the same direction: GLP-1 use is associated with lower alcohol consumption for at least some users
Those with significant joint disease should continue appropriate orthopedic or rheumatologic care while pursuing weight management strategies
Exenatide-induced depression in a geriatric patient
Jelly Roll, whose real name is Jason DeFord, opened up about his health, weight loss and fitness journey in the new Mens Health Winter 2026 Cover Story
Mr Israetel says he supports this expansion of supply and is downplaying the risk of pharmacy-compounded drugs
With dual COAs, reliable formulation sourcing, and clear compliance boundaries, the brand delivers on all three - making it not just a supplier, but a model for future lab-grade innovation